Podcasts about Tavi

Cardiovascular disease remains one of Australia's leading causes of death — and general practice sits at the heart of prevention, early detection and timely escalation.In this Heart Week episode of sMater, host Jillian Whiting and GP specialist Dr Maria Boulton are joined by Dr Nick Aroney, interventional and structural cardiologist at Mater, to unpack what frontline clinicians need to know right now.Together they explore:How much heart disease is truly preventableWhen CT coronary calcium scoring can change managementNavigating statins, soft plaque and patient resistanceRecognising atypical presentations, particularly in womenWhen symptoms should trigger urgent escalationThe quiet progression of valvular heart disease — and why auscultation still mattersHow advances like TAVI, AF ablation and heart–brain teams are reshaping outcomesThis is a practical, evidence‑informed conversation designed to support everyday decision‑making in general practice — when to reassure, when to escalate, and how evolving cardiology care can change lives.sMater is a podcast by clinicians, for clinicians, brought to you by Mater.To learn more about Mater, visit https://www.mater.org.au/

LBCT: Repeat Intervention After Failed Transcatheter Aortic Valve Implantation (TAVI): Outcomes of Redo TAVI Versus Surgical Explantation

Os 10 ensaios clínicos do ACC.26 que você precisa conhecer – discutidos por quem entende.Neste episódio especial do DozeCast, William, Rapha e Plínio se reúnem para destrinchar os principais Late-Breaking Trials apresentados no American College of Cardiology 2026 – o congresso que pautará a cardiologia mundial nos próximos meses.Da revascularização de oclusões crônicas (ORBITA-CTO) à decisão entre TAVI e angioplastia ( PRO-TAVI), passando pela prevenção cardiovascular (VESALIUS), insuficiência cardíaca (SPIRIT-HF, DIG- RHD),  oclusão do apêndice atrial (CHAMPION), tromboembolismo pulmonar de alto risco (HI-PEITHO) e muito mais! Cada estudo é analisado com olhar clínico, crítico e aplicável ao dia a dia.Se você quer sair do episódio sabendo o que mudou, o que confirmou e o que ainda gera dúvida após o ACC.26, esse é o conteúdo definitivo.

No Click Valvar de hoje temos grandes insights sobre angioplastia em pacientes TAVI e os critérios de fragilidade.

LBCT: TAVI CLOSE: Dual Suture Vs Single Suture and Plug Closure in Transfemoral TAVI

In this episode, our hosts are joined by Michael Borger and Nikolaos Bonaros to break down the new valvular heart disease guidelines—what's changed, why it matters, and how the decisions were really made. They cut through the headlines to explain the thinking behind key recommendations, from TAVI thresholds and bicuspid valves to atrial functional MR, concomitant ablation, and the push for heart valve centres. Sharp, practical, and grounded in real-world decision-making, this episode gives you the essentials of modern valve therapy—and the questions that still need answering.

LBCT: Long-term Outcomes of Women and Men Undergoing Self-Expanding Vs. Balloon Expandable Valves: A Sex-specific Analysis Of The SOLVE-TAVI Trial

Ultrarunner Tavi Wallace and Dallas Harshfield chatted with Terry Meiners on WHAS ahead of the Kentucky Derby Festival marathon and minimarathon to offer info about race pacers and tuneup runs.Most of the work should be done now that we are 10 days away but there is a fine art of following a race pacer to stay in the flow.Tavi has run incredibly long races over the years (including multiple 100 milers!) and offers advice to runners of all levels.Dallas has more details on scheduling and procedures, and insights into conquering the marathon at a fast walking pace.Best of luck to Tavi who'll run the Boston Marathon next week...her 3rd trip up Heartbreak Hill!  GO GET 'EM, TAVI and best of luck to all of our Kentuckiana runners.

Tavi Costa of Azuria Capital joins Trevor to outline his high-conviction thesis on the three most compelling sectors for the next decade: mining, energy, and Latin American emerging markets. Costa details how overwhelming global debt is driving a cycle of populism and deglobalization, which he views as the core force behind recent geopolitical friction and the resulting energy crunch. The conversation analyzes the "trickle-down" effects of $100 oil, specifically how it serves as a catalyst for a breakout in "lagger" agricultural commodities and creates a social risk through rising inequality. Highlighting his regional edge, Costa argues that Latin America is a "big winner" of the current global instability, offering underexplored resources and extremely low market-cap-to-GDP ratios in countries like Brazil and Argentina. Despite potential demand destruction, Costa remains a staunch copper bull, categorizing the metal as the ultimate bottleneck for the global build-out of AI and automation infrastructure. Finally, the episode explores a contrarian macro outlook where the Federal Reserve may be forced to cut interest rates to manage government debt and defense spending, potentially triggering a significant new round of the debasement trade.______Terrahutton empowers junior mining companies to secure investment with immersive, interactive, and visually striking storytelling. Learn more about the Terrahutton platform ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠______This episode of Mining Stock Daily is brought to you by... Revival Gold is one of the largest pure gold mine developer operating in the United States. The Company is advancing the Mercur Gold Project in Utah and mine permitting preparations and ongoing exploration at the Beartrack-Arnett Gold Project located in Idaho. Revival Gold is listed on the TSX Venture Exchange under the ticker symbol “RVG” and trades on the OTCQX Market under the ticker symbol “RVLGF”. Learn more about the company at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠revival-dash-gold.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Vizsla Silver is focused on becoming one of the world's largest single-asset silver producers through the exploration and development of the 100% owned Panuco-Copala silver-gold district in Sinaloa, Mexico. The company consolidated this historic district in 2019 and has now completed over 325,000 meters of drilling. The company has the world's largest, undeveloped high-grade silver resource. Learn more at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠https://vizslasilvercorp.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Equinox has recently completed the business combination with Calibre Mining to create an Americas-focused diversified gold producer with a portfolio of mines in five countries, anchored by two high-profile, long-life Canadian gold mines, Greenstone and Valentine. Learn more about the business and its operations at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠equinoxgold.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Integra Resources is a growing precious metals producer in the Great Basin of the Western United States. Integra is focused on demonstrating profitability and operational excellence at its principal operating asset, the Florida Canyon Mine, located in Nevada. In addition, Integra is committed to advancing its flagship development-stage heap leach projects: the past producing DeLamar Project located in southwestern Idaho, and the Nevada North Project located in western Nevada. Learn more about the business and their high industry standards over at integraresources.com

Witam Państwa, nazywam się Jarosław Drożdż, pracuję w Centralnym Szpitalu Klinicznym Uniwersytetu Medycznego w Łodzi, skąd nagrywam podcast Kardio Know-How. W tym odcinku omawiam pierwszą część badań opublikowanych podczas kongresu ACC 2026. Od lat sprzeciwiam się wykonywaniu badań i procedur, co do których nie mam przekonania klinicznego. Przykładem jest pacjent z ciężką stenozą aortalną kwalifikowany do TAVI, u którego w angio CT wykryto istotne zwężenia wieńcowe. W takich przypadkach pojawiają się trzy pytania: czy robić koronarografię, czy rewaskularyzację i co wykonać najpierw. Badanie PRO-TAVI (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00308-9/abstract?rss=yes) analizowało sens wykonywania rewaskularyzacji przed TAVI. Porównano strategię PCI przed TAVI z podejściem bezpośredniego TAVI i nie wykazano istotnych różnic w zgonach, zawałach czy udarach. Jednocześnie strategia bez PCI oznaczała aż o 92% mniej rewaskularyzacji oraz wyraźnie mniej krwawień i powikłań. Aktualne wytyczne ESC/PTK 2025 ograniczają wskazania do rewaskularyzacji, szczególnie przy zwężeniach

Topic: Malcolm and Carol get prepared for Sipp & Savor 2026 and welcome Octavio "Tavi" and Shannon Arzola to the show to talk about their unique businesses in Gulfport, Tavi's Salumeria and Pop Brothers. They discuss Tavi's Spanish heritage, culinary journey across the United States, and how he and his wife brought a unique European dining experience to the Gulf Coast. Guest(s): Octavio "Tavi" and Shannon Arzola Host(s): Malcolm White and Carol PalmerEmail: food@mpbonline.orgIf you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcast Hosted on Acast. See acast.com/privacy for more information.

Tavi Costa, founder and CEO of Azuria Capital, reveals three contrarian macro trades for which, he says, “people will call me crazy.” He also discusses the recent gold sell-off, which Costa argues does not fit a typical liquidation event since equities and treasuries were not crashing; he suggests an alternative possibility that Iran or other gray-area actors may have sold gold accumulated via oil trade outside the dollar system. Costa says the pullback created an oversold buying opportunity and expects gold to be multiples higher over 5–10 years, driven by dollar devaluation tied to U.S. twin deficits, central-bank buying, stagnant mine supply, deglobalization, and portfolio reallocation toward gold. He also addresses multipolarity and petrodollar concerns, favoring gradual shifts rather than a near-term reserve-currency change. Costa describes rotating across commodities, taking profits in energy, buying gold and quality miners, and adding contrarian options positions. 00:00 Intro 00:45 Gold Sell-off Explained 02:52 Middle East Gold Rumors 04:31 Buying the Dip 06:17 Gold Drivers Long Term 10:08 Petrodollar and Multipolarity 12:37 Commodity Rotation Strategy 15:40 How He Buys Gold 17:29 Three Mispriced Bets 20:29 Most Contrarian Wins 24:33 Brazil and Emerging Markets 26:59 Zeria Capital Mission 31:32 Where to Follow Tavi https://x.com/TaviCosta https://tavicosta.substack.com/ Sign up for our free newsletter and receive interview transcripts, stock profiles and investment ideas: http://eepurl.com/cHxJ39 This was not a sponsored interview. Mining Stock Education (MSE) offers informational content based on available data but it does not constitute investment, tax, or legal advice. It may not be appropriate for all situations or objectives. Readers and listeners should seek professional advice, make independent investigations and assessments before investing. MSE does not guarantee the accuracy or completeness of its content and should not be solely relied upon for investment decisions. MSE and its owner may hold financial interests in the companies discussed and can trade such securities without notice. If you buy stock in a company featured on MSE, for your own protection, you should assume that it is MSE's owner personally selling you that stock. MSE is biased towards its advertising sponsors which make this platform possible. MSE is not liable for representations, warranties, or omissions in its content. By accessing MSE content, users agree that MSE and its affiliates bear no liability related to the information provided or the investment decisions you make. Full disclaimer: https://www.miningstockeducation.com/disclaimer/

The TCTMD news team talks lipid guidelines, echo surveillance in AS, radiation for structural imagers, tirzepatide in TAVI, and conduction-system pacing.

No Click Valvar Academy de hoje temos grandes insights sobre CoreLabs ecocardiográficos em TAVI.

Waddup Petty Posse!  This episode of Baddies USA was straight chaos! DTB kicks things off by throwing a bag at Natalie and storming out, but the real drama unfolds at the Trill on Wheels party where the girls pull up drunk and ready to argue. Fania and Kold Killa press the Natalie vs. DTB issue, but things quickly shift to Tavi, who gets called out for inserting herself and “riding” for Natalie. The tension explodes into yelling, pushing, and messy confrontations until Tavi drops a bombshell about her close relationship with Fania, hinting there may be more going on behind the scenes

In this special TIO Congress edition of Parallax, Dr Ankur Kalra is joined by two of interventional cardiology's most influential voices: Professor Roxana Mehran, incoming President of the American College of Cardiology and Co-Course Director of TIO, and Professor Nicholas Van Mieghem, TIO Course Director. The conversation spans the evolution of online medical education, sex-specific differences in cardiovascular disease, and the challenge of translating clinical evidence into everyday practice. The guests explore sex as a biological variable across valve disease, plaque formation, and left ventricular remodeling, address the underdiagnosis of microvascular dysfunction in women, and examine persistent access barriers for female and non-white patients despite advances in trials such as SMART and RHEA. Professor Van Mieghem adds insights on modern TAVI planning and lifetime valve management, while Professor Mehran shares promising data on Factor XI inhibitors and the case for simplifying antithrombotic regimens. The episode closes on clinical inertia - with intravascular imaging uptake in the US still at just 12–15% despite a Class 1 indication, Professor Mehran outlines her ACC presidential vision: closing the gap between evidence and bedside practice, and reversing the troubling rise in cardiovascular morbidity and mortality. Questions and comments can be sent to podcast@radcliffe-group.com and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

No Click Valvar Academy de hoje temos grandes insights sobre os métodos multimodalidade na deterioração do TAVI.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart Centre University Hospital in Leipzig, SN, Germany; and Samuel Heuts, a cardiothoracic surgeon in the Department of Cardiothoracic Surgery at Maastricht University Medical Center in Maastricht, LI, about a paper they authored titled “Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk,” published in Heart, a journal produced by the British Medical Journal. Chapters 00:00 Intro 01:51 JANS 1, 6-Year Outcomes TAVR vs SAVR 06:45 JANS 2, Evolut THV Postdilation 09:22 Video 2, TAVI in SAVR Explantation 11:10 JANS 3, High Risk Increasing Adoption of DCD 13:17 JANS 4, Lobar Quantitation for Assessment 15:16 Video 1, Narayana Robotic AVR 17:23 Video 3, Extended Resections Podcast 18:30 Dr. Marin-Cuartas & Heuts, TAVR vs SAVR 36:42 Upcoming Events 37:32 Instructional Video Competition 38:55 Career Center They discussed the motivations behind the creation of this paper and provided insights into its Bayesian hierarchical design. Key findings included the five-year all-cause mortality rates and the risk of stroke associated with the procedures. They also referenced other studies with similar findings, such as a recently published paper from the Journal of the American College of Cardiology on the “Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.” Finally, they explored the future of transcatheter aortic valve implantation and surgical aortic valve replacement.   Joel also highlights recent JANS articles on the six-year outcomes after transcatheter vs surgical aortic valve replacement in low-risk patients with aortic stenosis, postdilation of Evolut transcatheter heart valves, insights into current practices in the United States regarding increasing adoption of donation after circulatory death in high-risk heart transplant recipients, and the value of V/Q SPECT/CT lobar quantitation for pre-treatment assessment of lung malignancy.  In addition, Joel explores robotic-assisted aortic valve replacement, TAVI in SAVR explantation, and an episode of The Atrium podcast featuring host Dr. Alice Copperwheat speaking with Dr. Maninder Kalkat about extended resections. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.) Six-Year Outcomes After Transcatheter vs Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis  2.) Postdilation of Evolut Transcatheter Heart Valves: Insights From Bench Testing  3.) Increasing Adoption of Donation After Circulatory Death in High Risk Heart Transplant Recipients: Insights Into Current Practices in the United States  4.) The Value of V/Q SPECT/CT Lobar Quantitation for Pre-Treatment Assessment of Lung Malignancy  CTSNet Content Mentioned  1.) Robotic-Assisted Aortic Valve Replacement   2.) TAVI in SAVR Explantation: A Two-Step Technique for Successful Removal   3.) The Atrium: Extended Resections   Other Items Mentioned  1.) Updated 5-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low- to Intermediate-Surgical Risk  2.) The Lifeline  3.) Instructional Video Competition     4.) Career Center   5.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Ungārija un Slovākija bloķē sankcijas pret Krieviju un aizdevumu Ukrainai. Šķietami arvien nestabilāka kļūst partija “Stabilitātei!”. Šomēnes no tās valdes izslēgti vēl divi locekļi – Saeimas deputāti Igors Judins un Jefimijs Klementjevs. Biedrības "Tavi draugi" telpās notiek plakātu darbnīca "Kopā līdz uzvarai!", kuru jau ceturto gadu rīko "Latvijas Platforma attīstības sadarbībai", Fonds atvērtai sabiedrībai "DOTS" un biedrība "Tavi draugi". Ķekavas novada dome lems par Baldones sākumskolas pievienošanu vidusskolai.

WORRIED ABOUT THE MARKET? SCHEDULE YOUR FREE PORTFOLIO REVIEW with Thoughtful Money's endorsed financial advisors at https://www.thoughtfulmoney.comToday's guest has been predicting an oncoming boom in the commodity complex for a while now.And increasingly, it's starting to look like that boom is arriving.If so, how high will it go? And how long will it last?And where may the best opportunities lie for investors?For answers, we turn to macro and commodities expert Tavi Costa formely of Crescat Capital. but now newly running his own show at Azuria Capital.#commodities #gold #oilandgas _____________________________________________ Thoughtful Money LLC is a Registered Investment Advisor Promoter.We produce educational content geared for the individual investor. It's important to note that this content is NOT investment advice, individual or otherwise, nor should be construed as such.We recommend that most investors, especially if inexperienced, should consider benefiting from the direction and guidance of a qualified financial advisor registered with the U.S. Securities and Exchange Commission (SEC) or state securities regulators who can develop & implement a personalized financial plan based on a customer's unique goals, needs & risk tolerance.IMPORTANT NOTE: There are risks associated with investing in securities.Investing in stocks, bonds, exchange traded funds, mutual funds, money market funds, and other types of securities involve risk of loss. Loss of principal is possible. Some high risk investments may use leverage, which will accentuate gains & losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods.A security's or a firm's past investment performance is not a guarantee or predictor of future investment performance.Thoughtful Money and the Thoughtful Money logo are trademarks of Thoughtful Money LLC.Copyright © 2026 Thoughtful Money LLC. All rights reserved.

Listener feedback, the value of procedural volume for TAVR and MTEER, ventricular arrhythmia in older athletes, and the Goldilocks time horizon for predicting and modifying CV risk are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Procedural Volume and Outcomes for TAVI and M-TEER Operator Procedural Volumes and Outcomes for TAVR and MTEER https://jamanetwork.com/journals/jamacardiology/fullarticle/2843740 II Ventricular Arrhythmia in Older Male Endurance Athletes Myocardial Fibrosis May Raise Arrhythmia Risk in Older Male Endurance Athletes https://www.medscape.com/viewarticle/myocardial-fibrosis-may-raise-arrhythmia-risk-older-male-2026a10001y0 Timing and Relationship of VA With Exercise Patterns in Older Male Endurance Athletes https://doi.org/10.1093/eurjpc/zwag021 III Predicting Cardiac Risk and Statin Use 30-Year ASCVD Risk Among US Adults Aged 30-59 https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.125.012348 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This episode covers: Cardiology This Week: A concise summary of recent studies What´s new in TAVI?  Digital solutions in arrhythmias Mythbusters - Gratitude is heart healthy Host: Emer Joyce Guests: JP Carpenter, Davide Capodanno, Fleur Tjong Want to watch that episode? Go to: https://esc365.escardio.org/event/2528 Want to watch that extended interview on Digital solutions in arrhythmias, go to: https://esc365.escardio.org/event/2528?resource=interview Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. Emer Joyce has declared to have potential conflicts of interest to report: Alnylam, Bayer, Pfizer, Fire-1. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson. Fleur Tjong has declared to have potential conflicts of interest to report: Amsterdam UMC Innovation grant, Heath Holland TKI, Abbott, Dutch Research Council, Boston Scientific.

In this powerful kickoff to 2026, Craig Hemke for Sprott Money welcomes macro strategist and investor Tavi Costa to discuss the massive shifts brewing in global markets. Tavi unveils key macro trends for 2026, including the asymmetric opportunity in energy, the undervaluation in gold and silver mining stocks, and a major capital rotation into hard assets. With inflation risks rising and financial repression likely ahead, Tavi explains why the setup for commodities — especially gold, silver, and copper — is just getting started. They also explore Latin America's investment potential, the mining sector's structural underinvestment, and the role of sovereign actors in driving private market activity. This is essential listening for anyone looking to buy gold or silver, or to understand where the silver and gold prices are headed next.

No episódio de hoje do Check-up Semanal, o Dr. Ronaldo Gismondi, editor-chefe médico do Portal Afya e do Whitebook, comenta os principais destaques recentes em Cardiologia publicados no Portal Afya, reunindo as evidências mais relevantes para a prática clínica atual.Artigos mencionados:• Angioplastia imediata vs. estagiada de lesões não culpadas no IAM com supra de ST• Eficácia e segurança da continuidade da anticoagulação no periprocedimento da TAVI• Colchicina na prevenção de eventos cardiovasculares: o que dizem as evidências?• Deficiência de ferro na insuficiência cardíaca: qual o melhor parâmetro prognóstico?• Eficácia do atenolol no tratamento anti-hipertensivo: novos dados brasileiros

Today we are exploring Left Atrial Appendage Occlusion or LAAO Therapy.  We explore the clinical rationale, patient selection, referral pathways and key considerations for LAAO. and aim to understand the therapy as an option for patients who are unsuitable for long term anticoagulation therapy. This is a sponsored podcast.A/Prof Pankaj Jain is an academic interventional cardiologist with appointments at Royal Prince Alfred, Concord, and Macquarie University Hospitals. He is a Clinical Senior Lecturer at the University of Sydney, and Conjoint Senior Lecturer at the University of New South Wales. His interests include complex coronary and structural heart interventions, and mechanical support devices for heart failure.Dr Ata Doost is an Interventional  Cardiologist. He completed his training at various hospitals throughout Australia and undertook his speciality fellowship training at Kings College Hospital in London   He has appointments at Macquarie University Hospital and National Capital Private & Calvary Bruce Hospitals  in Canberra and is a Senior Clinical lecturer at Macquarie University Medical School. Dr Doost has performed thousands of cardiac catheterisations and has extensive experience in structural heart procedures. He specialises in coronary interventions, advanced imaging, and valve therapies including TAVI and MitraClip. 

Tavi ha sido visto por un niño y su magia empieza a desvanecerse. Entre risas, luces y un último intento por creer en sí mismo, deberá encontrar la forma de salvar su magia y descubrir si aún puede convertirse en un verdadero elfo de Santa Claus.

Tavi se une a una clase especial donde los elfos fabrican objetos que dan alegría. Su creación parece no funcionar, pero todos, incluido él mismo, se llevan una enorme sorpresa.

Tavi, un pequeño elfo lleno de ilusión, llega por fin a la Escuela de Elfos de Santa Claus. Allí todo es mágico… excepto su larga bufanda, que solo le causa problemas. Cuando un accidente arruina una importante actividad, Tavi deberá decidir si sigue su sueño o renuncia.

An elegant study in post-TAVI atrioventricular block, a PSA for my structural colleagues, revascularization in women, and a CTO PCI trial are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I AV Block After TAVR Heart Blocks During vs After TAVR Show Distinct Patterns https://www.medscape.com/viewarticle/heart-blocks-during-vs-after-tavr-show-distinct-patterns-2025a1000ypp Mechanisms Underlying Alterations in Cardiac Conduction After TAVR https://jamanetwork.com/journals/jamacardiology/fullarticle/2842748 II Related PSA Announcement to My Structural Colleagues III Revascularization Strategies in Women with Severe Chronic CAD Women With Chronic Severe CAD Fare Better With CABG vs PCI https://www.medscape.com/viewarticle/women-chronic-severe-cad-fare-better-cabg-vs-pci-2025a1000ygd PCI vs CABG in Women With Chronic CAD https://doi.org/10.1093/eurheartj/ehaf806 PCI vs CABG - Meta-Analysis of 4 RCTs https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02334-5/abstract CABG vs Drug-Eluting Stent Implantation for CAD - Meta-Analysis https://www.jacc.org/doi/10.1016/j.jcin.2016.10.008 RECHARGE trial https://therechargetrial.com/ IV A CTO PCI RCT – But don't get your hopes up Early vs Late-Staged PCI After Subintimal Tracking and Re-entry for CTO https://doi.org/10.1016/j.jacc.2025.09.1598 DECISION CTO trial https://pubmed.ncbi.nlm.nih.gov/30813758/ National Inpatient Sample Database PCI CTO Associated With Higher Mortality https://pubmed.ncbi.nlm.nih.gov/37356643/ V Mandrola's Top 10 Stories You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

The Ugly Sweater Fun Run is coming soon. Tavi Wallace, the ultrarunner who knows no limits, brought Dream Factory CEO Tommie Kendall along to describe its amazing work for children with dire medical needs.Tavi loves shining light on incredible compassionate pursuits, and how runners can help!

On this Weekend Show, Tavi Costa and Dan Steffens walk through where they see real value today: high-quality junior precious and base metal names positioned for M&A, and a structurally tightening energy market led by natural gas and overlooked oil producers. It's a big-picture roadmap for investors who want to own the next leg of the resource bull market.   Segment 1 & 2 - Tavi Costa, Partner at Crescat Capital, joins us to share his big-picture outlook on where he sees the best value in the resource space, from junior precious-metal explorers and the majors' slow approach to M&A, to his growing conviction in copper, zinc, and energy (oil and gas) as both key opportunities and a hedge for mining investors. Click here to visit the Crescat Capital website  The opinions and information shared by Tavi in this discussion are his own, and not necessarily those of Crescat. Any investments discussed may or may not be held by Crescat. Investments carry risk including risk of loss.   Segment 3 & 4 - Dan Steffens, President of the Energy Prospectus Group, wraps up the show sharing his bullish outlook on natural gas driven by winter weather, rising LNG exports, and growing power demand, while also outlining why he believes oil fundamentals remain tighter than current prices suggest and where he sees the best opportunities in oil and gas equities amid an active M&A environment. Click here to visit the Energy Prospectus Group website for more energy market and stock analysis   If you enjoy the show, be sure to subscribe to our podcast feed (KER Podcast), YouTube channel, and follow us on X for more market commentary and company interviews. Don't forget to subscribe and leave us a review!   For more market commentary & interview summaries, subscribe to our Substacks: The KE Report: https://kereport.substack.com/ Shad's resource market commentary: https://excelsiorprosperity.substack.com/   Investment disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any security. Investing in equities and commodities involves risk, including the possible loss of principal. Do your own research and consult a licensed financial advisor before making any investment decisions. Guests may own shares in companies mentioned.

Dr. Emile Daoud, Deputy Editor of JACC Clinical Electrophysiology, discusses Risk Stratification in LBBB after TAVI: Comparison Between a Novel ECG Algorithm and ESC Criteria.

Impact of Cerebral Embolic Protection on Cognition: Experience from BHF PROTECT-TAVI

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Dr Mehdi Eskandari from King's College Hospital, London. They discuss his paper that attempts to use machine learning to identify patients in whom a TAVI procedure is likely to be unsuccessful, using simple, readily available variables. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper: https://heart.bmj.com/content/early/2025/07/25/heartjnl-2025-325928

Today we are exploring cardiac surgery in elderly patients.This podcast is sponsored by Macquarie University Hospital, part of Macquarie University Health – a trailblazer in healthcare, education and research.Professor Michael Vallely is a leading cardiothoracic surgeon who has clinical and academic interests in minimising the invasiveness of cardiothoracic surgery and is a world authority on total arterial, anaortic, off-pump coronary artery bypass surgery. He also has interests in minimally invasive cardiac surgery (MICS and Da Vinci robotic surgery), transcatheter (TAVI and Mitra-Clip) cardiac surgery, thoracic aortic surgery, geriatric cardiac surgery, and hybrid procedures including the use of ECMO.Dr Nargis Shaheen is a consultant geriatrician with a special interest in perioperative medicine working at Macquarie University Hospital and Concord Hospital. She is a member of the ANZCA perioperative care working group and is involved in perioperative medicine teaching.

IPD Meta-Analysis of Contemporary Trials Comparing TAVI versus SAVR

Acest material poate conține mesaje publicitare și plasare de produse. Unele dintre produsele, serviciile sau brandurile menționate sunt promovate prin parteneriate comerciale, iar prezentarea acestora reprezintă o reclamă.Opiniile exprimate de gazde și invitați sunt personale și nu reflectă neapărat poziția oficială a sponsorilor sau partenerilor noștri. Încurajăm publicul să efectueze propria cercetare înainte de a lua decizii bazate pe informațiile prezentate în acest podcast.

This episode of JACC This Week, hosted by Harlan M. Krumholz, MD, SM, highlights key research and perspectives from the October 14, 2025 issue of JACC. It opens with a call to modernize physician certification by distinguishing core knowledge from clinical reasoning, emphasizing continuous, engaging learning over rote memorization. Featured studies in this week's issue include the cardiovascular risks linked to clonal hematopoiesis in older women, improved clotting outcomes with third-generation LVADs despite ongoing bleeding risks, and how dapagliflozin reduces heart failure events post-TAVI without improving perceived quality of life. The episode also explores inflammation as a target after myocardial infarction, the evolving role of drug-coated balloons in PCI, and cardiac CT's expanding use in prosthetic valve assessment—signaling a shift toward more precise, less invasive cardiovascular care. We also feature an article from JACC: Asia this week on cardiovascular Implications of lipoprotein(a) and its genetic variants in patients from the Middle East.

Two great stories of translation science leading to beneficial drugs in terrible diseases of the heart and the Sisyphean task of predicting the need for pacing after TAVI are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Sotatercept HYPERION Trial https://www.nejm.org/doi/10.1056/NEJMoa2508170 ZENITH Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2415160 Evidence report on treatment for PAH https://icer.org/news-insights/press-releases/icer-publishes-final-evidence-report-on-treatment-for-pulmonary-arterial-hypertension/ PAH Sotatercept Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2503944 II Acoramidis and ATTR Cardiomyopathy ATTRIBUTE-CM Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2305434?logout=true ATTRIBUTE-CM Analysis - Substudy https://www.jacc.org/doi/10.1016/j.jacc.2025.09.013 Tafamadis Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1805689 III Pacing After TAVI Prophylactic pacemaker after TAVI https://www.jacc.org/doi/10.1016/j.jacep.2025.07.028 PROMOTE study https://doi.org/10.1016/j.hrthm.2024.12.019 Evaluation of ESC criteria on RBBB patients undergoing TAVI https://doi.org/10.1016/j.hrthm.2024.11.030 Editorial on Heart Rhythm journal papers https://www.heartrhythmjournal.com/article/S1547-5271(25)00114-6/abstract You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

This past episode was too much! Summer has been doing a lot as usual and not everyone is feeling it. Tavi continues to "demand" her respect from Big Lex, but it's starting to get a little embarrassing. In Addition, with Natalie gone, it seems that Rollie has taken charge, calling the shots this episode! Is Rollie the REAL BADDIES CEO? Tune in and join us in this week's dose of mess!  Also check out Tiana's Sims Channel below!    Tiana's Sims Channel: https://www.youtube.com/@pettysimproductions   NEW EPISODES EVERY TUESDAY AT 4PM =========================== Connect with us! ============================= https://www.instagram.com/randommania1 https://www.instagram.com/jessi.strange https://www.tiktok.com/@pettysimproductions =========================== Subscribe and Listen to the The Petty Headquarters Podcast HERE: =========================== ➡︎YT: @ThePettyHeadquarters ➡︎Apple: https://podcasts.apple.com/us/podcast/is-summer-the-star-of-the-show-baddies-midwest-recap-ep-3-4/id1703678575?i=1000677723578 ➡︎Spotify: https://open.spotify.com/episode/4SAiUiY4ZBfMsax2uIR0ph?si=BFomx4dMQoyKUJZJ8OZjAg   Our mission is to stay on top of the mess and make sure we deliver it weekly!

Stijn Schmitz welcomes Tavi Costa to the show. Tavi Costa is Macro Strategist at Crescat Capital. Costa shares a compelling personal journey from Brazil, where experiencing hyperinflation shaped his financial perspective, to becoming a tennis player and eventually a finance professional. His background in macro analysis has enabled him to identify significant market turning points, such as predicting China's potential economic challenges and the emerging commodity trends. Costa emphasizes the importance of independent research and developing strong conviction in investment strategies. He discusses the current bullish environment for gold and silver, highlighting a notable chart showing central banks increasingly preferring gold over treasuries. He believes the current gold market has substantial potential, potentially surpassing historical performance due to unprecedented economic conditions. Regarding silver, Costa presents an intriguing 45-year cup and handle technical pattern, suggesting the potential for silver prices to reach triple digits. He argues that limited silver exploration assets and increasing demand from various sectors could drive significant price appreciation. Moreover, he sees tremendous opportunity in mining companies, noting their impressive profit margins and potential for institutional attraction. Costa is also becoming bullish on energy, presenting a contrarian view based on declining oil inventories, reduced drilling activities, and potential increased energy consumption from technological developments like AI. He sees the energy sector as an undervalued asset class with significant medium-term potential. At Crescat Capital, Costa focuses on early-stage exploration companies, employing a venture capital approach in the mining space. He believes in actively helping management improve capital allocation and exploration strategies. His investment philosophy centers on identifying intrinsic value in companies before market recognition, with a particular focus on metals and resources. Throughout the discussion, Costa emphasizes flexibility in investment thinking, the importance of independent research, and the potential for significant shifts in market perception toward traditionally underappreciated sectors like mining and energy.

This episode covers: Cardiology This Week: A concise summary of recent studies Strategic decisions in valvular heart disease Optimising drug therapy in chronic coronary syndromes Mythbusters: Does wearing a white coat make you smarter? Host: Susanna Price Guests: John-Paul Carpenter, Fabien Praz, Robert Storey Want to watch that episode? Go to: https://esc365.escardio.org/event/2092 Want to watch that extended interview on Optimising drug therapy in chronic coronary syndromes ? Go to: https://esc365.escardio.org/event/2092?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English-language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel, Fabien Praz and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Robert Storey has declared to have potential conflicts of interest to report: research grants and personal fees from AstraZeneca and Cytosorbents, and personal fees from Abbott, Afortiori Development/Thrombolytic Science, Boehringer Ingelheim/Lilly, Bristol Myers Squibb/Johnson & Johnson, Chiesi, Idorsia/Viatris, Novo Nordisk, PhaseBio and Tabuk. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Precious metals are starting to move. Otavio Costa was pounding the table on gold and silver back in 2023. This is a replay of that conversation. I hope you guys enjoy!Hey Guys! This episode, we hear from Tavi Costa, portfolio manager at Crescat Capital, and get his insights into the precious metals industry. Tavi talks about the importance of precious metals CAPEX and explains how the demand for precious metals, specifically gold, affects the industry. He also discusses the differing opinions of gold bears. Tavi shares his thoughts on the inflation super cycle and how it impacts investing criteria. He also talks about identifying mistakes and valuing precious metals equities.[0:00] Who is Tavi Costa?[6:00] Precious Metals CAPEX[22:00] PM Demand: The Use of Gold[33:00] Gold Bears[40:00] The Inflation Super Cycle[50:00] Investing Criteria[59:00] Identifying Mistakes[1:08:00] Valuing PM Equities[1:19:00] More from Tavi Costa and Closing QuestionsIf you enjoyed this podcast, please check out Otavio on Twitter ⁠@TaviCosta⁠ and read his latest research at ⁠Crescat Capital⁠. Finally, thanks to the following sponsors for making the podcast a reality!MitimcoThis episode is brought to you by MIT Investment Management Company, also known as MITIMCo, the investment office of MIT. Each year, MITIMCo invests in a handful of new emerging managers who it believes can earn exceptional long-term returns to support MIT's mission. To help the emerging manager community more broadly, they created ⁠emergingmanagers.org⁠, a website for emerging manager stockpickers.I highly recommend the site for those looking to start a stock-picking fund or learn how others have done it. You'll find essays and interviews by successful emerging managers, service providers used by MIT's own managers, essays MITIMCo has written for emerging managers, and more!

Is silver finally ready to explode higher? Crescat Capital's Tavi Costa joins Wealthion's Trey Reik to share why he believes silver is entering a powerful new bull market, and why most investors still don't see it coming. From surging industrial demand for solar and AI infrastructure, to a historic supply crunch and under-the-radar central bank buying, Tavi explains why silver may be the most undervalued macro asset on the planet.

“The U.S. Treasury's gold reserves are at one of the lowest levels in 90 years,” says Tavi Costa, partner and portfolio manager at Crescat Capital, joining Daniela Cambone on the Daniela Cambone Show. “At just 2% of total government debt, this imbalance is a green light for long-term gold investors.”Costa warns that rising U.S. debt, surging interest costs, and the likelihood of dollar devaluation will eventually force the government to either buy more gold or revalue it, a move he believes could unlock massive upside for the metal. “The world is accumulating gold, and the U.S. will have to join in,” he says. Beyond gold, Costa shares why the AI arms race and a coming infrastructure boom could reshape the U.S. economy, creating major opportunities in raw materials and engineering sectors.The opinions and information shared by Tavi in this discussion are his own, and not necessarily those of Crescat. Any investments discussed may or may not be held by Crescat. Investments carry risk including risk of loss. ✅ FREE RESOURCESDownload the Ultimate Decision-Making Guide on Gold & Silver plus Daniela Cambone's Top 10 Lessons to safeguard your wealth (FREE)

In this podcast interview, Tavi Costa from Crescat Capital discusses the emerging bullish cycle in the metals and mining sector, highlighting several key macro trends and investment opportunities. Costa believes we are in the early stages of a long-term commodity cycle, with gold leading the way and other metals poised to follow. The discussion centers on three primary pillars: energy sources, infrastructure, and raw materials. Costa argues that the increasing electricity demand, driven by artificial intelligence and onshoring trends, will create significant opportunities in metals and mining. He emphasizes the critical need for metals to support emerging technological and infrastructure developments, particularly in the United States. A pivotal moment Costa highlights is the U.S. Department of Defense's 15% stake in MP Materials, which he sees as a recognition of strategic material vulnerabilities. This investment signals a potential shift in how governments view critical resources and mining infrastructure. Costa also discusses the potential macroeconomic trajectory, suggesting two potential paths: a deflationary shock or an inflationary era followed by a highly efficient, deflationary period driven by AI. He believes we are currently in an inflationary buildup phase that will eventually transition to increased productivity and efficiency. Regarding currencies, Costa anticipates a long-term decline in the U.S. dollar versus other currencies, driven by significant fiscal and trade deficits. He sees this as part of a broader "domino effect" of macro trends, where acceptance of risk gradually moves through different asset classes and markets. The interview concludes with Costa identifying the exploration and development phase of the mining industry, alongside emerging markets, as potentially the most asymmetric investment opportunities of his career. He encourages investors to pay attention to the interconnected nature of these macro trends and the gradual rotation of capital across different sectors and geographies.

Featuring articles on routine cerebral embolic protection for TAVI, and treatments for cirrhosis due to MASH, BRAF V600E metastatic colorectal cancer, and Pompe's disease; a new review article series on medical education; a case report of a woman with dyspnea on exertion; and Perspectives on addressing ultraprocessed foods, on the costs of dismantling DEI, and on a brother's keeper.

Today Guy talks about word eizé, “what a,” a word we frequently use in various contexts. How do we use it, and what happens when we add it to mashehu, “something,” or mishehu, “someone”? Hear the All-Hebrew Episode on Patreon   New Words and Expressions: Eizo mis'ada – What a restaurant – איזו מסעדה Eize mis'ada (coll.) / Ssssé mis'ada – What a restaurant – איזה מסעדה Eize basa – What a bummer – איזה באסה Eize ben adam – What a person – איזה בן אדם Eize fashla – What a mess-up – איזה פשלה Eize hagzamot! – Such exaggeration! – !איזה הגזמות Eize hisachfut! – That's so over-the-top! – !איזה היסחפות Eize keta/kta'im –  How funny/What a surprise – איזה קטע/קטעים Eize keif lishmo'a – So happy to hear (the news) – איזה כיף לשמוע Eize yoffie – How great – איזה יופי Eize nefila – What a flop – איזה נפילה Eize fisfus – What a bummer – איזה פספוס Wow, eize rishmiyut – Wow, such formality – וואו, איזה רשמיות Eize hultsa lilbosh, zot o zot? – Which shirt should I wear, this one or that one? – איזה חולצה ללבוש, זאת או זאת Eize rofe – Which doctor – איזה רופא (Be-) eize yom? – On what day? – איזה יום Chikiti eize sha'a – I waited for like an hour – חיכיתי איזה שעה Tamlits li al eize sefer – Could you recommend a book for me? – תמליץ לי על איזה ספר Haya sham eize mishehu – There was some guy there – היה שם איזה מישהו Tavi eize mashehu – Get me something – תביא איזה משהו   Playlist and Clips: Dudu Tassa – Eize Yom (lyrics) Dalia Amihud – Eize Ben Adam (lyrics) Ep. no. 51 about yofi Ep. no. 108 about basa, bummer Ep. no. 112 about rishmiyoot, formality Ep. no. 115 about fisfoos, loss Ep. no. 118 about nefila, flop Ep. no. 132 about keta, gag Ep. no. 137 about hagzamot, exaggerations Ep. no. 143 about fashla, mess-up

Why can't you divide by zero? Neil deGrasse Tyson and Chuck Nice discuss higher dimensions, dividing by zero, and math's unsolved questions with math YouTuber Grant Sanderson (3blue1brown).NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here:https://startalkmedia.com/show/the-language-of-the-universe-with-grant-sanderson-3blue1brown/Thanks to our Patrons Nicolas Alcayaga, Ryan Harris, Ken Carter, Ryan, Marine Mike USMC, VARD, Mile Milkovski, Gideon Grimm Gaming, Shams.Shafiei, Ben Goldman, Zayed Ahmed, Matt Nash, Stardust Detective, Leanice, morgoth7, Mary O'Hara, David TIlley, Eddie, Adam Isbell-Thorp. Armen Danielyan, Tavi, Matthew S Goodman, Jeremy Brownstein, Eric Springer, Viggo Edvard Hoff, Katie, Kate Snyder, Jamelith, Stanislaw, Ringo Nixon, Barbara Rothstein, Mike Kerklin, Wenis, Ron Sonntag, Susan Brown, Anti alluvion, Basel Dadsi, LoveliestDreams, Jenrose81, Raymond, David Burr, Shadi Al Abani, Bromopar, Zachary Sherwood, VP, Southwest Virginia accountability, Georgina Satchell, Nathan Arroyo, Jason Williams, Spencer Bladow, Sankalp Shinde, John Parker, Edward Clausen Jr, William Duncanson, Mark, and Dalton Evans for supporting us this week. Subscribe to SiriusXM Podcasts+ to listen to new episodes of StarTalk Radio ad-free and a whole week early.Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus.